The Patent Finder

Cytovia, Inc.

Also on record
Records under this name other than patents Cytovia, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cytovia, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,968,595Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof
Lapsed on the fee record
Ended Jun 28, 2023 · USPTO record
Lapsed on the fee recordEnded Jun 28, 2023USPTO record
US 6,858,6077,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
Term ended
Term ended Aug 29, 2022 · USPTO record
Term endedTerm ended Aug 29, 2022USPTO record
US 6,794,4004-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
Term ended
Term ended Jul 27, 2022 · USPTO record
Term endedTerm ended Jul 27, 2022USPTO record
US 7,618,9754-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
Formerly held
Lapsed on the fee record
Ended Nov 17, 2021 · USPTO record
Lapsed on the fee recordEnded Nov 17, 2021USPTO record
US 8,258,145Method of treating brain cancer
Formerly held
Lapsed on the fee record
Ended Sep 4, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 4, 2020USPTO record
US 6,248,904Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
Term ended
Term ended Jul 21, 2019 · USPTO record
Term endedTerm ended Jul 21, 2019USPTO record
US 6,153,591Dipeptide caspase inhibitors and the use thereof
Term ended
Term ended Mar 16, 2019 · USPTO record
Term endedTerm ended Mar 16, 2019USPTO record
US 6,184,210Dipeptide apoptosis inhibitors and the use thereof
Term ended
Term ended Mar 16, 2019 · USPTO record
Term endedTerm ended Mar 16, 2019USPTO record
US 6,335,429Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
Term ended
Term ended Oct 9, 2018 · USPTO record
Term endedTerm ended Oct 9, 2018USPTO record
US 7,622,497Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
Lapsed on the fee record
Ended Nov 24, 2017 · USPTO record
Lapsed on the fee recordEnded Nov 24, 2017USPTO record
10 of 50 patents shown.
Pro members see all 50.
Pro members: see all 50 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited